COVID-19 case numbers are trending up in the U.S. once more, with nearly all new infections driven by the growth of the Omicron subvariant BA.2.
At the same time, the U.S. hasn’t yet seen a dramatic rise in cases, and COVID-19 hospitalizations and deaths are still at low levels. Public health officials are watching the numbers to determine what could happen next.
“We are certainly seeing the beginning of a surge in new infections,” Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, told CNN.
In an ideal scenario, he said, the U.S. would reach transmission rates that are “low enough” to not disrupt “our daily economic, workplace and social lives.” Until then, Americans have to be prepared to take precautions and calculate their own risks.
“It depends on how high we go up in the surge, and it depends on whether the surge is associated with an increase in severe disease,” he said. “I can’t say where we are right now because we’re transitioning.”
BA.2 accounted for 86% of new COVID-19 cases last week, according to the latest CDC update. About 34,000 cases are being reported each day, according to the national data tracker for The New York Times, which marks a 22% increase during the past two weeks.
Even still, the case numbers are some of the lowest since July 2021. This week’s jump in cases could be related to a two-week backlog in Florida, CNN reported. In addition, hospitalizations and deaths are still declining, with about 15,000 COVID-19 patients hospitalized nationwide and about 500 deaths being reported each day.
At the state level, cases are increasing in 25 states, falling in 16 states and steady in nine states, CNN reported. Cases are rising most in the Northeast, where BA.2 makes up more than 90% of cases.
Philadelphia became the first major city to announce that it would reinstate indoor mask requirements. Cases increased 50% in 10 days, which surpassed the city’s limit for reimposing mask mandates.
Several universities have also reinstated indoor masking, CNN reported, including American University, Georgetown University, George Washington University and Johns Hopkins University.
“I suspect that this wave will be smaller than the one we saw in January,” Cheryl Bettigole, MD, the public health commissioner of Philadelphia, said Monday during a news briefing.
“But if we wait to find out and to put our masks back on, we’ll have lost our chance to stop the wave,” she added.
The global tally of COVID-19 cases surpassed 500 million, according to UPI, increasing from 300 million in early January to 400 million in early February to half a billion this week.
Worldwide spread appears to be slowing, with the number of daily cases about 37% lower than two weeks ago, according to the global data tracker from The New York Times. Fewer than 1 million cases are being reported each day, down from 2 million daily cases about a month ago.
In addition, the global number of COVID-19 deaths is about 31% lower than two weeks ago, with an average of 3,300 deaths being reported each day.
more recommended stories
-
Gut Microbiome Predicts Long COVID Risk
In a recent pre-print study published.
-
COVID-19 & Autoimmune Care Hope: Natural Proteins
Recent research at Umeå University reveals.
-
FasL Inhibitor Asunercept Speeds COVID-19 Recovery
A new clinical trial demonstrates that.
-
Impact of COVID-19 mRNA Vaccine on Myocardial Scarring
A new study found a greater.
-
Long-term Cognitive and Psychiatric Issues in COVID-19 Survivors
A new study published in The.
-
Mental Health and COVID-19: Unequal Impacts in LA County
A recent study published in the.
-
Neuropsychiatric Risks in COVID-19 Survivors: Key Study Findings
Researchers employed a large, binational cohort.
-
Pregnancy Outcomes: COVID-19 Vaccine Effects
Researchers examined the reactogenicity and effects.
-
IgG from Long COVID Patients Induces Symptoms in Mice
In a recent study published on.
-
Enhanced Immune Response in New COVID-19 Vaccines
An improved vaccination offers an enhanced.
Leave a Comment